Carrier effects on biological activity of amphotericin B.
about
Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of ParacoccidioidomycosisAspergillus fumigatus and aspergillosisPolymeric Nanoparticles of Brazilian Red Propolis Extract: Preparation, Characterization, Antioxidant and Leishmanicidal Activity.Caveats associated with the use of human cervical tissue for HIV and microbicide research.Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformansEfficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.Atrioventricular block related to liposomal amphotericin B.Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.Water-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovaniA novel injectable water-soluble amphotericin B-arabinogalactan conjugateDistribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits.In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective propertiesComparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbitsToxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.In vitro and in vivo interactions between miltefosine and other antileishmanial drugsStructures, targets and recent approaches in anti-leishmanial drug discovery and development.Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell cultureAntifungal prophylaxis during neutropenia and immunodeficiencyHow can micelle systems be rebuilt by a heating process?In Vitro Antifungal Activity and Mode of Action of 2',4'-Dihydroxychalcone against Aspergillus fumigatus.Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B.Optimizing efficacy of amphotericin B through nanomodification.N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.The Role of Signaling via Aqueous Pore Formation in Resistance Responses to Amphotericin BNanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potencyHydroxychavicol: A phytochemical targeting cutaneous fungal infections.Neurotrophic natural products: chemistry and biology.Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Complexation of amphotericin B and curcumin with serum albumins: solubility and effect on erythrocyte membrane damage.
P2860
Q28550277-075329CB-0407-4B91-99DA-62523838F81BQ29617908-2D3A5559-B8A0-46BC-BA6F-56E573EACBA2Q30382963-CD875736-8CEA-4CA3-9152-C421F57BAFDBQ33515006-ED755B49-740F-44AC-A31B-2CA55741E5DAQ33689898-15D5EBE2-EA3D-4CA9-9AA3-20151CF1AA38Q33694175-29D80FDA-29BC-4176-B392-A4ABE9F0793DQ33702731-91D5DD14-48E3-4480-8AA2-2DA9C7A442F0Q33744152-FA44C01A-F6E2-42B4-A4F2-9A9CCA9F11F3Q33798459-41BA3313-0F11-47A7-A874-180E4C442C84Q33823803-D4540C19-1469-4DBB-B2FF-BDFEFA3970DAQ33938137-35E22CD3-823A-485B-93C4-D0BD99B1BE30Q33976111-86FB2845-D3EC-4617-A4C2-CF4024919343Q33977425-33C2D5EE-9F7B-4D40-862D-9B7978D62A84Q33978764-D01F6A94-38C9-4916-9037-3C937CA92532Q33979132-ACFAF9ED-4CEA-4454-BD4B-04246EF10F36Q33980296-AB480B43-A761-4551-8C3E-5651E36847DEQ33981451-EEA1F0E1-9183-46C7-AF03-ABD98C0838F9Q34160941-B6948C75-8D7E-4298-931F-DCD3C7317FDCQ34229980-BCC422A5-9E91-4D79-B7E0-6AB509D07B3DQ34230457-C83F1F13-BF9A-4BC5-98E5-2D928890FE73Q34251910-C0704BCB-2259-43E6-9C0D-6F10DB3B8804Q34298854-DDD839F2-CC11-4BD2-8064-41AA059BA07DQ34301638-7674CD6D-65B8-4234-BFB2-EB66FB40D8E3Q35012968-19D87ECA-D027-4DFB-9238-A21D1207F58BQ35091593-51E682C9-5689-4287-8B96-6285B626C6FAQ35168703-C0B6CA30-2AF1-4298-9634-88B4D3613F06Q35363496-82F5CB55-18B5-4AAE-97E4-014C633ED4C3Q35374928-7CB28615-440F-454E-972F-1912524A961CQ35686909-B30D807D-3877-4D37-8387-FDEB4EE77B31Q35697196-04F6AEE9-BEEA-43C3-A636-F75A95929846Q36272948-94184DA9-B8EB-43FB-98E4-DC70EEDF0F80Q36920328-227EB6CB-2D3C-48A4-839D-D555C1DD782AQ37159459-C5784FA3-5C21-4A8F-A7E4-9AFBEFDC0C10Q37203821-AA3E6DA7-3C2E-4ECA-B26C-4504FC07DA89Q37401889-B1E48690-96EC-4A6E-9174-D88D081555CCQ37449337-67A54DCA-6ACC-4B4C-81C2-1FCA16FA2202Q37623342-957E0698-DB24-43EB-8B25-00F87BD5BB7BQ38342306-0545BA32-F869-4019-8670-5DD7C20647B7Q38681635-A82D4AEA-3741-4AFC-87F1-839577AE9E6CQ38836051-2AAD9125-A7CA-4D9E-A01C-59A8975BEE81
P2860
Carrier effects on biological activity of amphotericin B.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Carrier effects on biological activity of amphotericin B.
@ast
Carrier effects on biological activity of amphotericin B.
@en
type
label
Carrier effects on biological activity of amphotericin B.
@ast
Carrier effects on biological activity of amphotericin B.
@en
prefLabel
Carrier effects on biological activity of amphotericin B.
@ast
Carrier effects on biological activity of amphotericin B.
@en
P2860
P1476
Carrier effects on biological activity of amphotericin B.
@en
P2093
P2860
P304
P407
P577
1996-10-01T00:00:00Z